Establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines. 2018

Michael Gock, and Christina S Mullins, and Carina Bergner, and Friedrich Prall, and Robert Ramer, and Anja Göder, and Oliver H Krämer, and Falko Lange, and Bernd J Krause, and Ernst Klar, and Michael Linnebacher
Department of General Surgery, University Medical Center, Rostock 18055, Germany.

OBJECTIVE To establish patient-individual tumor models of rectal cancer for analyses of novel biomarkers, individual response prediction and individual therapy regimens. METHODS Establishment of cell lines was conducted by direct in vitro culturing and in vivo xenografting with subsequent in vitro culturing. Cell lines were in-depth characterized concerning morphological features, invasive and migratory behavior, phenotype, molecular profile including mutational analysis, protein expression, and confirmation of origin by DNA fingerprint. Assessment of chemosensitivity towards an extensive range of current chemotherapeutic drugs and of radiosensitivity was performed including analysis of a combined radio- and chemotherapeutic treatment. In addition, glucose metabolism was assessed with 18F-fluorodeoxyglucose (FDG) and proliferation with 18F-fluorothymidine. RESULTS We describe the establishment of ultra-low passage rectal cancer cell lines of three patients suffering from rectal cancer. Two cell lines (HROC126, HROC284Met) were established directly from tumor specimens while HROC239 T0 M1 was established subsequent to xenografting of the tumor. Molecular analysis classified all three cell lines as CIMP-0/ non-MSI-H (sporadic standard) type. Mutational analysis revealed following mutational profiles: HROC126: APC , TP53 , KRAS , BRAF , PTEN ; HROC239 T0 M1: APC , P53 , KRAS , BRAF , PTEN and HROC284Met: APC , P53 , KRAS , BRAF , PTEN . All cell lines could be characterized as epithelial (EpCAM+) tumor cells with equivalent morphologic features and comparable growth kinetics. The cell lines displayed a heterogeneous response toward chemotherapy, radiotherapy and their combined application. HROC126 showed a highly radio-resistant phenotype and HROC284Met was more susceptible to a combined radiochemotherapy than HROC126 and HROC239 T0 M1. Analysis of 18F-FDG uptake displayed a markedly reduced FDG uptake of all three cell lines after combined radiochemotherapy. CONCLUSIONS These newly established and in-depth characterized ultra-low passage rectal cancer cell lines provide a useful instrument for analysis of biological characteristics of rectal cancer.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011836 Radiation Tolerance The ability of some cells or tissues to survive lethal doses of IONIZING RADIATION. Tolerance depends on the species, cell type, and physical and chemical variables, including RADIATION-PROTECTIVE AGENTS and RADIATION-SENSITIZING AGENTS. Radiation Sensitivity,Radiosensitivity,Sensitivity, Radiation,Tolerance, Radiation,Radiation Sensitivities,Radiation Tolerances,Radiosensitivities,Sensitivities, Radiation,Tolerances, Radiation
D012004 Rectal Neoplasms Tumors or cancer of the RECTUM. Cancer of Rectum,Rectal Cancer,Rectal Tumors,Cancer of the Rectum,Neoplasms, Rectal,Rectum Cancer,Rectum Neoplasms,Cancer, Rectal,Cancer, Rectum,Neoplasm, Rectal,Neoplasm, Rectum,Rectal Cancers,Rectal Neoplasm,Rectal Tumor,Rectum Cancers,Rectum Neoplasm,Tumor, Rectal
D012007 Rectum The distal segment of the LARGE INTESTINE, between the SIGMOID COLON and the ANAL CANAL. Rectums
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D004847 Epithelial Cells Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional epithelial cells. Adenomatous Epithelial Cells,Columnar Glandular Epithelial Cells,Cuboidal Glandular Epithelial Cells,Glandular Epithelial Cells,Squamous Cells,Squamous Epithelial Cells,Transitional Epithelial Cells,Adenomatous Epithelial Cell,Cell, Adenomatous Epithelial,Cell, Epithelial,Cell, Glandular Epithelial,Cell, Squamous,Cell, Squamous Epithelial,Cell, Transitional Epithelial,Cells, Adenomatous Epithelial,Cells, Epithelial,Cells, Glandular Epithelial,Cells, Squamous,Cells, Squamous Epithelial,Cells, Transitional Epithelial,Epithelial Cell,Epithelial Cell, Adenomatous,Epithelial Cell, Glandular,Epithelial Cell, Squamous,Epithelial Cell, Transitional,Epithelial Cells, Adenomatous,Epithelial Cells, Glandular,Epithelial Cells, Squamous,Epithelial Cells, Transitional,Glandular Epithelial Cell,Squamous Cell,Squamous Epithelial Cell,Transitional Epithelial Cell

Related Publications

Michael Gock, and Christina S Mullins, and Carina Bergner, and Friedrich Prall, and Robert Ramer, and Anja Göder, and Oliver H Krämer, and Falko Lange, and Bernd J Krause, and Ernst Klar, and Michael Linnebacher
July 2022, Human cell,
Michael Gock, and Christina S Mullins, and Carina Bergner, and Friedrich Prall, and Robert Ramer, and Anja Göder, and Oliver H Krämer, and Falko Lange, and Bernd J Krause, and Ernst Klar, and Michael Linnebacher
November 2021, Human cell,
Michael Gock, and Christina S Mullins, and Carina Bergner, and Friedrich Prall, and Robert Ramer, and Anja Göder, and Oliver H Krämer, and Falko Lange, and Bernd J Krause, and Ernst Klar, and Michael Linnebacher
September 1988, Nihon Sanka Fujinka Gakkai zasshi,
Michael Gock, and Christina S Mullins, and Carina Bergner, and Friedrich Prall, and Robert Ramer, and Anja Göder, and Oliver H Krämer, and Falko Lange, and Bernd J Krause, and Ernst Klar, and Michael Linnebacher
September 2023, Human cell,
Michael Gock, and Christina S Mullins, and Carina Bergner, and Friedrich Prall, and Robert Ramer, and Anja Göder, and Oliver H Krämer, and Falko Lange, and Bernd J Krause, and Ernst Klar, and Michael Linnebacher
April 2020, Biological research,
Michael Gock, and Christina S Mullins, and Carina Bergner, and Friedrich Prall, and Robert Ramer, and Anja Göder, and Oliver H Krämer, and Falko Lange, and Bernd J Krause, and Ernst Klar, and Michael Linnebacher
January 2014, PloS one,
Michael Gock, and Christina S Mullins, and Carina Bergner, and Friedrich Prall, and Robert Ramer, and Anja Göder, and Oliver H Krämer, and Falko Lange, and Bernd J Krause, and Ernst Klar, and Michael Linnebacher
May 1998, International journal of cancer,
Michael Gock, and Christina S Mullins, and Carina Bergner, and Friedrich Prall, and Robert Ramer, and Anja Göder, and Oliver H Krämer, and Falko Lange, and Bernd J Krause, and Ernst Klar, and Michael Linnebacher
January 2005, Clinical & experimental metastasis,
Michael Gock, and Christina S Mullins, and Carina Bergner, and Friedrich Prall, and Robert Ramer, and Anja Göder, and Oliver H Krämer, and Falko Lange, and Bernd J Krause, and Ernst Klar, and Michael Linnebacher
January 2017, Cancer cell international,
Michael Gock, and Christina S Mullins, and Carina Bergner, and Friedrich Prall, and Robert Ramer, and Anja Göder, and Oliver H Krämer, and Falko Lange, and Bernd J Krause, and Ernst Klar, and Michael Linnebacher
January 2009, Cancer cell international,
Copied contents to your clipboard!